PW–REF13 / Synthetic peptide

Selank

TP-7

VIAL RECORD10 mgIDENTITYCATALOGUE RECORDDOCUMENT SET02 SECTIONS
RESEARCH USE ONLY — CONTROLLED IN-VITRO LABORATORY RESEARCH
SPECIMEN / PW–REF13● LIVE RECORD
Selank research reference vial

DOCUMENT REGISTER / PW–REF13

COMPOUND
DOCUMENTATION.

Review identity, analytical and classification records associated with this compound. Documents apply only to the compound and batch identifiers displayed.
01SUPPLIER REFERENCES LISTED

MANUFACTURER-SUPPLIED DOCUMENTATION

Manufacturer-supplied COA

Laboratory report references published by your identified supplier, JEEP Peptides. The issuing laboratory is Janoshik; these are not tests commissioned by Peptide ProDirect.

Supplier reference
SK10
Supplier-listed sample size
10 mg
Laboratory named in source
Janoshik Analytical
Supplier-listed laboratory reportReport 123505 · 10 mg

Supplier reference only. A match to Peptide ProDirect stock batches has not been established. Reference sizes are supplier sample labels, not measured assay results. Read the original report for its sample details and findings; unverified results are not reproduced here.

View supplier document source ↗
02PRODUCT INFORMATION SUMMARY

PRODUCT CLASSIFICATION

Product classification

A retailer-prepared description of the catalogue identity, presentation and declared purpose. This is not a regulatory classification decision or a certificate of analysis.

Catalogue identity
Selank
Catalogue category
Synthetic peptide
Labelled vial quantity
10 mg
Presentation
Vial
Declared intended purpose
Controlled in-vitro laboratory research
Record prepared by
Peptide ProDirect

Prepared from the Peptide ProDirect catalogue. Unknown composition, batch characteristics and regulatory determinations are omitted. No HPRA approval or authorisation is asserted.

HPRA classification guidance ↗

RESEARCH USE ONLY

NO HUMAN OR
VETERINARY USE.

All records displayed here relate to materials supplied solely for controlled in-vitro laboratory research. Products are not offered for administration, ingestion, injection, diagnosis, treatment or therapeutic use.

Product classification depends on objective characteristics, composition, presentation, claims and actual intended use. Peptide Prodirect does not claim HPRA approval, authorisation or endorsement.

READ HPRA CLASSIFICATION GUIDANCE ↗